Immuneering (IMRX)Director bought ~$50K

~$50K

Approx. value · 7,500 sh @ $6.67

157K

Holds after · shares reported

Traded

Oct 3, 2025

Filed

Oct 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 24, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
2. Sep 24, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
3. Sep 29, 2025InsiderDirector purchased ~$36K of IMRX shares in the open market
4. Oct 3, 2025 · this disclosureInsiderDirector purchased ~$50K of IMRX shares in the open market

What came next

1. Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
2. Jan 12, 2026InsiderDirector purchased ~$87K of IMRX shares in the open market
3. Jan 13, 2026InsiderOfficer purchased ~$11K of IMRX shares in the open market
4. Jan 15, 2026Insider · 2 peopleInsiders: 2 purchases (~$112K)
5. Jan 16, 2026Insider · 5 insiders in a week, 4th time since 2021Officer purchased ~$25K of IMRX shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Immuneering

OQRO holds no insider, Congress, fund or contract record for Immuneering dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMRX page.

Other recent filings by Peter Feinberg, Director

• SEC Form 4 at Immuneering (IMRX)Jan 14, 2026
• SEC Form 4 at Immuneering (IMRX)Sep 30, 2025
• SEC Form 4 at Immuneering (IMRX)Jun 23, 2025

The full history of Peter Feinberg, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Immuneering

• SEC Form 4Jun 24, 2026
• SEC Form 4Jun 16, 2026
• SEC Form 4Jan 21, 2026
• SEC Form 4Jan 20, 2026
• SEC Form 4Jan 16, 2026
• SEC Form 4Jan 15, 2026

Everything OQRO holds on this company is on its IMRX page.